Get Your Team Back to Work

Add COVID-19 Antibody Testing as Part of your Employee Return-to-Work Program

Many companies have implemented antibody testing as part of their phased, employee return-to-work strategy. According to the latest CDC Guidance the presence of antibodies, detectable several weeks after symptom onset, “suggests that infectiousness likely is greatly decreased and that some degree of immunity from future infection has developed”
(Review full Guidance for further details)

Learn about the TestGet the Test
CornaCheck Test Team

About 20/20 GeneSystems

20/20 GeneSystems is a U.S. based digital diagnostics company that harnesses the power of A.I. and big data analytics to reduce cancer mortality around the world through early detection. We have created innovative tests built around our proprietary algorithms to detect more than 6 common cancers. In the US, we also operate our own CLIA certified laboratory, catering to the needs of US consumers in our home market. We currently operate globally through partners, in Asia, the Middle East and Europe.

20/20 also has a proud history spanning almost 20 years of assisting first responders through innovative cancer screening as well as other biotech products.

Why Partner with 20/20 GeneSystems?


  1. We provide 3 different types of testing solutions
  2. We offer cooperative advertising programs

BioCheck Kits

Our BioCheck kits are used by to detect suspicious powder by hundreds of departments around the US.

OneTest for Cancer

Our cutting-edge OneTest uses AI to help detect many common cancers via a single blood draw.

CoronaCheck Tests

CoronaCheck Tests are a series of serology tests offered and distributed by 20/20 in the US and Canada.
Office Workers